SCHEMBL22340949

SCHEMBL22340949

CCCC(C)N(CCc1ccccc1)Cc1ccc(OC)cc1

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BCHE P06276 3/20 0.62
SIGMAR1 Q99720 2/20 0.48
ALOX5 P09917 2/20 0.46
LPAR1 Q92633 1/20 0.46
LPAR5 Q9H1C0 1/20 0.46
KCNH2 Q12809 2/20 0.45
AOC3 Q16853 3/20 0.45
ALDH1A1 P00352 3/20 0.44
TSHR P16473 3/20 0.44
SMN1; SMN2 Q16637 2/20 0.44
SLC22A2 O15244 1/20 0.44
SLC22A1 O15245 1/20 0.44
SLC22A3 O75751 1/20 0.44
ESR1 P03372 1/20 0.44
CHRM2 P08172 1/20 0.44
HTR1A P08908 1/20 0.44
ADRA2A P08913 1/20 0.44
ADORA3 P0DMS8 1/20 0.44
CHRM1 P11229 1/20 0.44
DRD2 P14416 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22340675 0.89 BCHE (0.58) BCHESIGMAR1ALOX5LPAR1LPAR5
SCHEMBL22340945 0.86 BCHE (0.56) BCHEAOC3SMN1; SMN2TAS2R14LMNA
SCHEMBL20871295 0.85 ALOX5 (0.51) BCHESIGMAR1ALOX5LPAR1LPAR5
SCHEMBL13286274 0.81 BCHE (0.46) BCHEALDH1A1TSHROPRM1TAS2R14
SCHEMBL18079510 0.78 BCHE (0.51) BCHESIGMAR1KCNH2AOC3ALDH1A1
SCHEMBL22340659 0.77 BCHE (0.52) BCHEAOC3ALDH1A1SMN1; SMN2TAS2R14
SCHEMBL29336127 0.76 BCHE (0.67) BCHESIGMAR1ALOX5KCNH2TSHR
SCHEMBL20871191 0.76 SMN1; SMN2 (0.45) BCHEALDH1A1TSHRSMN1; SMN2CYP3A4
SCHEMBL20870840 0.76 BCHE (0.52) BCHESIGMAR1TSHRSMN1; SMN2CYP1A2
SCHEMBL29335335 0.76 AOC3 (0.54) BCHEALOX5LPAR1LPAR5KCNH2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11034646-B2 Method for the synthesis of unsymmetrical tertiary amines Universite Paris-Saclay (FR) 2021-06-15 US disclosed
US-20200255369-A1 NEW METHOD FOR THE SYNTHESIS OF UNSYMMETRICAL TERTIARY AMINES Universite Paris-Saclay (FR) 2020-08-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200255369-A1 NEW METHOD FOR THE SYNTHESIS OF UNSYMMETRICAL TERTIARY AMINES ADH1C, ADH1A, ADH5 BCHE 307/4885SIGMAR1 54/4885ALOX5 1892/4885
US-11034646-B2 Method for the synthesis of unsymmetrical tertiary amines ADH1C, PNMT, ADH1A BCHE 256/4885SIGMAR1 85/4885ALOX5 2000/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.